A reduced functionality of Gi proteins as a possible cause of fibromyalgia

Journal of Rheumatology

Volumn 28, Issue 10, 2001, Pages 2298-2304

  Galeotti, N ^a   Ghelardini, C ^a   Zoppi, M ^a   Del Bene, E ^a   Raimondi, L ^a   Beneforti, E ^a   Bartolini, A ^a  

^a Department of Pharmacology ^*  (Italy)

Author keywords

cAMP; Diagnosis; Fibromyalgia; Gi protein hypofunctionality; Lymphocytes; Reduced adenylate cyclase activity

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME ACTIVITY; FEMALE; FIBROMYALGIA; HUMAN; HYPERALGESIA; MALE; NEUROPATHY; NOCICEPTION; OSTEOARTHRITIS; PAIN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ADENYLATE CYCLASE; ADULT; AGED; AGED, 80 AND OVER; CYCLIC AMP; FEMALE; FIBROMYALGIA; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 0034795952     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Fibromyalgia: Generalized pain intolerance and manifold symptoms reporting
2. Symptoms mimicking neurologic disorders in fibromyalgia syndrome
3. Fibromyalgia: The clinical syndrome
4. Pain perception and personality measures as discriminators in the classification of fibrositis
5. An overview of psychologic studies in fibromyalgia
6. A controlled study of primary fibromyalgia syndrome: Clinical features and association with other functional syndromes
7. The concept of primary fibromyalgia (fibrositis) clinical value, relation and significance to other chronic musculoskeletal pain syndromes
8. Fibromyalgia syndrome a decade later
9. Sleep and circadian rhythm in fibromyalgia
10. Chronic muscular pain: Aetiology and pathogenesis
11. Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: A model for referral of muscle pain?
12. Lack of association between fibromyalgia syndome and abnormalities in muscle energy metabolism
13. Neurochemical pathogenesis of fibromyalgia
14. Fibromyalgia is not a muscle disorder
15. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis
16. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia. New features for diagnosis
17. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue
18. Diversity of G proteins in signal transduction
19. G proteins
20. Structure and function of signal-transducing GTP-binding proteins
21. Modulation of ion-channel function by G-protein-coupled receptors
22. G-protein mechanisms: Insights from structural analysis
23. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosilation of a membrane protein
24. 3H-nitrendipine binding to synaptic membranes: Similarity with morphine tolerance
25. Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception
26. Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice
27. Pertussis toxin inhibits the antinociceptive action of morphine in the rat
28. Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channel
29. The American College of Rheumatology criteria for the classification of fibromyalgia. Report of the multicenter criteria committee
30. Isolation of mononuclear cells and granulocytes from human blood
31. Granulocyte-macrophage colony-stimulating factor primes neutrophils by activating a pertussis toxin-sensitive G protein not associated with phosphatidylinositol turnover
32. Inhibitory effects of pertussis toxin on the cAMP generating system in human mononuclear leucocytes
33. 2- adrenoceptors
34. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
35. Pertussis toxin treatment in vivo is associated with a decline in G-protein β-subunits
36. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells
37. Functional maturation of human lymphocytes is accompanied by changes in the G-protein pattern
38. Preservation of Gi-protein inhibited adenylyl cyclase activity in the brains of patients with Alzheimer's disease
39. Insulin-mediated sensitization of adenylyl cyclase activation
40. Signal transduction by guanine nucleotide binding proteins
41. Giα2 mediates the inhibitory regulation of adenylyl cyclase in vivo: Analysis in transgenic mice with Giα2 suppressed by inducible antisense RNA
42. i2 transducer proteins on μ/δ opioid-mediated supraspinal antinociception
43. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception
44. i3 transducer proteins
45. Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients
46. Pertussis toxin treatment of whole blood. A novel approach to assess G protein function in congestive heart failure
47. Impaired G-proteins and cyclic nucleotide phosphodiesterase activity in T-lymphocytes from patients with sarcoidosis
48. Differential expression of guanosine triphosphate binding proteins in men at high and low risk for the future development of alcholism
49. High levels of Gs in platelets of euthymic patients with bipolar disorders